ADRB2 is an important regulator of the neuroimmune response after ischemic stroke and affects the inflammatory response of microglia/macrophages [64], and inhibition of ADRB2-mediated upregulation of HIF-1α can reduce blood-brain barrier damage during acute cerebral ischemia [65]. Here, ADRB2 is linked to ischemic stroke.